CCL3 has also been implicated as a factor leading to microenvironmental dysfunction in a variety of malignancies including myelodysplastic syndrome (MDS), metastatic disease of renal cell carcinoma, and B-Cell lymphomas8–11. Here, CCL3 is linked to myelodysplastic syndrome.